Document is current
Any future updates will be listed below
-
Authors
Budhwani, Karim I. https://orcid.org/0000-0001-8823-1695
-
Funding
Funding for this research was provided by:
National Science Foundation (TI-2321805)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1R43CA254493-01)
- License Information
-
More Information
Article History
Received: 7 June 2024
Revised: 15 August 2024
Accepted: 27 August 2024
First Online: 3 September 2024
Competing interests
: KIB’s work has been funded by the NIH, the NSF, the Breast Cancer Research Foundation of Alabama, and Innovate Alabama. He is CEO-Scientist of CerFlux and is co-inventor of issued (and pending) patents pertaining to in vitro, in silico, ex vivo, and cancer supermodel technologies.
